SG Americas Securities LLC Cuts Holdings in Cabot Corporation $CBT

SG Americas Securities LLC cut its holdings in shares of Cabot Corporation (NYSE:CBT) by 75.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,079 shares of the specialty chemicals company’s stock after selling 27,222 shares during the period. SG Americas Securities LLC’s holdings in Cabot were worth $684,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of CBT. Norges Bank purchased a new stake in Cabot during the fourth quarter valued at $49,662,000. AQR Capital Management LLC grew its position in Cabot by 123.0% during the second quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after buying an additional 478,702 shares during the period. UBS Group AG increased its holdings in Cabot by 186.7% during the third quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock valued at $45,136,000 after buying an additional 386,514 shares during the last quarter. Pacer Advisors Inc. raised its position in Cabot by 3,165.7% in the fourth quarter. Pacer Advisors Inc. now owns 229,252 shares of the specialty chemicals company’s stock worth $15,195,000 after acquiring an additional 222,232 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new position in Cabot during the fourth quarter valued at $8,785,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Trading Down 0.5%

Shares of NYSE CBT traded down $0.40 during trading hours on Tuesday, hitting $87.20. 5,654 shares of the company traded hands, compared to its average volume of 478,357. The company’s 50 day moving average price is $84.75 and its 200 day moving average price is $76.65. Cabot Corporation has a 12 month low of $58.33 and a 12 month high of $94.53. The stock has a market capitalization of $4.50 billion, a price-to-earnings ratio of 16.52, a price-to-earnings-growth ratio of 11.36 and a beta of 0.83. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.30 million. During the same quarter last year, the firm earned $1.90 earnings per share. The firm’s quarterly revenue was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, equities research analysts anticipate that Cabot Corporation will post 6.34 earnings per share for the current fiscal year.

Cabot Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Friday, May 29th were given a $0.4725 dividend. This represents a $1.89 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend was Friday, May 29th. This is a boost from Cabot’s previous quarterly dividend of $0.45. Cabot’s dividend payout ratio is currently 35.73%.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. Mizuho raised their target price on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, June 25th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. JPMorgan Chase & Co. increased their price objective on shares of Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. Finally, Truist Financial initiated coverage on Cabot in a report on Monday, June 8th. They issued a “buy” rating and a $98.00 price target on the stock. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $85.80.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.